Addressing Prostate Cancer Information Disparities with eHealth Technology
利用电子医疗技术解决前列腺癌信息差异
基本信息
- 批准号:8741958
- 负责人:
- 金额:$ 16.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-25 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Access to InformationAddressAdvisory CommitteesAdvocateAffectAfrican AmericanAgeAttentionBenefits and RisksCaringClinicClinicalCommunitiesComplexComputersDataDecision AidDecision MakingDiagnosisDiseaseEarly DiagnosisElementsEnrollmentFoundationsFundingGoalsGuidelinesHealth systemHealthcareHospitalsInterventionIsraelKnowledgeLeadMalignant neoplasm of prostateMedicalMedical centerMethodsNetwork-basedOnline SystemsOutcomeParticipantPatientsPerceptionPhysiciansPilot ProjectsPre-Post TestsPreparationPreventivePrimary Health CarePrimary PreventionProceduresProcessProstate-Specific AntigenProviderRecommendationRecruitment ActivityReportingResearchRiskScienceScientific Advances and AccomplishmentsScreening for Prostate CancerSelf EfficacyServicesSurveysTechnologyTestingTimeTreatment EfficacyUpdateVisitWorkWorkplacebaseclinical practicecostdesigneHealthempoweredhigh riskimprovedmenpatient orientedpreferenceprimary care settingprimary outcomepublic health relevancescreeningsecondary outcomeshared decision makingtherapy designtherapy developmenttool
项目摘要
DESCRIPTION (provided by applicant): Prostate cancer (CaP) is a prevalent and serious disease with no known methods of primary prevention. African American (AA) men are disproportionately affected by CaP; they are 60% more likely to be diagnosed and nearly 2.5 times more likely to die from the disease than White men. Screening with prostate specific antigen (PSA) is the main method of early detection, although it remains of unproven benefit. Major medical organizations debate the potential benefits versus harms of prostate cancer screening (PCS), but they all emphasize educating men about the potential limitations, risks and benefits of PCS, and helping them to make individualized decisions with their medical providers ("shared decision-making," or SDM). Nonetheless, this is not the norm in clinical practice, especially for AA men. Numerous decision aids (DAs) have been developed to help men make informed decisions regarding PCS. Unlike most prior PCS studies, however, we have developed a culturally relevant DA; make use of low cost, modern technologies to deliver the multi-media, individually tailored DA; gather data from patients and providers to study the dyad; and assess the potential for integration of PCSPrep into clinical practice. We address these research gaps by testing the Prostate Cancer Screening Preparation (PCSPrep) -- a tailored, interactive, Web-based, and culturally relevant DA -- on outcomes related to SDM among AA men. Primary care providers (PCP) affiliated with Beth Israel Deaconess Medical Center will be recruited. From each PCP, we will recruit and enroll 10 AA men ages 45-70 (N=100). Study participants will complete a pre-test, PCSPrep, and post-test immediately prior to a routine medical visit. PCS discussions between patient and provider will be audio-taped and both patients and providers will complete assessments immediately after the visit. Specific aims are to estimate the impact of PCSPrep on: (1) patients' PCS knowledge, decision self-efficacy, and decisional consistency; (2) providers' perceptions of patient engagement, concordance between provider/patient ratings of SDM; and (3) feasibility and acceptability of integrating PCSPrep
into primary care practice. The ultimate goal is to reduce disparities in access to high quality information about PCS and to empower AA men to be active participants in their care. Results will not only inform decision-making for PCS, but can inform the development of interventions for other conditions or procedures that call for SDM.
描述(由申请人提供):前列腺癌(CaP)是一种流行且严重的疾病,尚无已知的一级预防方法。非裔美国人 (AA) 男性受 CapP 的影响尤为严重;与白人相比,他们被诊断出这种疾病的可能性高出 60%,死于该疾病的可能性高出近 2.5 倍。前列腺特异性抗原(PSA)筛查是早期检测的主要方法,尽管其益处尚未得到证实。主要医疗组织对前列腺癌筛查 (PCS) 的潜在益处与危害存在争议,但他们都强调教育男性了解 PCS 的潜在局限性、风险和益处,并帮助他们与医疗提供者做出个性化决策(“共同决策”)。制作,”或SDM)。尽管如此,这在临床实践中并不常见,尤其是对于 AA 男性来说。已经开发出许多决策辅助工具 (DA) 来帮助男性做出有关 PCS 的明智决策。然而,与大多数先前的 PCS 研究不同,我们开发了一个与文化相关的 DA;利用低成本的现代技术来提供多媒体、个性化定制的 DA;从患者和提供者那里收集数据来研究二元组;并评估 PCSPrep 融入临床实践的潜力。我们通过测试前列腺癌筛查准备 (PCSPrep)(一种量身定制的、交互式的、基于网络且具有文化相关性的 DA)来弥补这些研究空白,测试 AA 男性中与 SDM 相关的结果。将招募贝斯以色列女执事医疗中心附属的初级保健提供者 (PCP)。我们将从每位 PCP 中招募并招募 10 名 45-70 岁的 AA 男性 (N=100)。研究参与者将在例行医疗就诊之前立即完成预测试、PCSPrep 和后测试。患者和提供者之间的 PCS 讨论将被录音,患者和提供者将在访问后立即完成评估。具体目标是评估 PCSPrep 对以下方面的影响:(1)患者的 PCS 知识、决策自我效能和决策一致性; (2) 提供者对患者参与度的看法,提供者/患者对 SDM 评级之间的一致性; (3) 集成PCSPrep的可行性和可接受性
进入初级保健实践。最终目标是减少获取有关 PCS 的高质量信息的差距,并让 AA 男性积极参与他们的护理。结果不仅可以为 PCS 的决策提供信息,还可以为需要 SDM 的其他病症或程序的干预措施的制定提供信息。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of a Prostate Cancer Screening Decision Aid for African-American Men in Primary Care Settings.
- DOI:10.1158/1055-9965.epi-20-0454
- 发表时间:2020-11
- 期刊:
- 影响因子:0
- 作者:Allen JD;Filson CP;Berry DL
- 通讯作者:Berry DL
Does Shared Decision-Making for Prostate Cancer Screening Among African American Men Happen? It Depends on Who You Ask.
非裔美国男性是否会就前列腺癌筛查做出共同决策?
- DOI:10.1007/s40615-021-01064-x
- 发表时间:2022
- 期刊:
- 影响因子:3.9
- 作者:Allen,JenniferD;Porteny,Thalia;Kaplan,Amy;Ladin,Keren;Monahan,Kyle;Berry,DonnaL
- 通讯作者:Berry,DonnaL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Dacey Allen其他文献
Jennifer Dacey Allen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Dacey Allen', 18)}}的其他基金
Addressing Prostate Cancer Information Disparities with eHealth Technology
利用电子医疗技术解决前列腺癌信息差异
- 批准号:
8568348 - 财政年份:2013
- 资助金额:
$ 16.78万 - 项目类别:
Promoting Utilization of Cancer Early Detection Methods among Latinos in Church:
促进教会中拉丁裔癌症早期检测方法的使用:
- 批准号:
8294986 - 财政年份:2011
- 资助金额:
$ 16.78万 - 项目类别:
Promoting Utilization of Cancer Early Detection Methods among Latinos in Church:
促进教会中拉丁裔癌症早期检测方法的使用:
- 批准号:
8065805 - 财政年份:2010
- 资助金额:
$ 16.78万 - 项目类别:
Understanding the dissemination of evidence-based interventions through churches
了解通过教会传播循证干预措施
- 批准号:
8048318 - 财政年份:2010
- 资助金额:
$ 16.78万 - 项目类别:
Understanding the dissemination of evidence-based interventions through churches
了解通过教会传播循证干预措施
- 批准号:
8147761 - 财政年份:2010
- 资助金额:
$ 16.78万 - 项目类别:
Promoting Utilization of Cancer Early Detection Methods among Latinos in Church:
促进教会中拉丁裔癌症早期检测方法的使用:
- 批准号:
8378214 - 财政年份:
- 资助金额:
$ 16.78万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT
平均风险成人结直肠癌筛查的有效性:结肠镜检查与 FIT
- 批准号:
10132734 - 财政年份:2017
- 资助金额:
$ 16.78万 - 项目类别:
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT
平均风险成人结直肠癌筛查的有效性:结肠镜检查与 FIT
- 批准号:
9905394 - 财政年份:2017
- 资助金额:
$ 16.78万 - 项目类别:
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT
平均风险成人结直肠癌筛查的有效性:结肠镜检查与 FIT
- 批准号:
10026306 - 财政年份:2017
- 资助金额:
$ 16.78万 - 项目类别:
PROMIS-Deaf Profile: Inclusion of Deaf Patients in Disability and Outcomes Research
PROMIS-聋人概况:将聋人患者纳入残疾和结果研究
- 批准号:
9116140 - 财政年份:2015
- 资助金额:
$ 16.78万 - 项目类别: